CVRx (CVRX) vs Fractyl Health (GUTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Fractyl Health (GUTS) has outperformed CVRx (CVRX) over the past year, losing 74.8% versus a loss of 81.6%. Fractyl Health is the larger company by market cap ($56.1 million vs $44.8 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVRX | GUTS |
|---|---|---|
| Share price | $1.68 | $4.23 |
| Market cap | $44.76M | $56.11M |
| 1-day change | +0.60% | -6.42% |
| YTD return | -76.34% | -83.98% |
| 1-year return | -81.56% | -74.82% |
| 5-year return | -89.27% | — |
| EPS (TTM) | $-1.97 | $-10.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.30 | $29.34 |
| 52-week low | $1.50 | $4.14 |
| Distance from 52-week high | -85.13% | -85.58% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +172.62% | +1327.90% |
| Average volume | 922.12K | 156.16K |
| Shares outstanding | 26.64M | 13.26M |
| Employees | 223 | 100 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CVRx
CVRX stock →CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
Health Care · Medical/Dental Instruments · 223 employees
About Fractyl Health
GUTS stock →Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans.
Health Care · Medical/Dental Instruments · 100 employees
CVRX vs GUTS FAQ
Which is bigger, CVRx or Fractyl Health?
Fractyl Health (GUTS) is larger, with a market capitalization of $56.11M compared with $44.76M for CVRx (CVRX).
Which stock has performed better over the past year, CVRX or GUTS?
GUTS returned -74.82% over the past 12 months, compared with -81.56% for CVRX (price return, excluding dividends). Past performance does not predict future results.
Are CVRx and Fractyl Health in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.